• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Large owner Windsor Private Capital Lp sold $290,185 worth of shares (130,753 units at $2.22) (SEC Form 4)

    10/22/25 6:36:23 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology
    Get the next $AIFF alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
    X
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Windsor Private Capital LP

    (Last) (First) (Middle)
    22 ST. CLAIR AVENUE EAST
    SUITE 202

    (Street)
    TORONTO A6 M4T 2S3

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    FIREFLY NEUROSCIENCE, INC. [ AIFF ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    10/20/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock(1) 10/20/2025 S(2) 33,500 D $2.457 1,334,026 I See footnote(3)
    Common Stock(1) 10/21/2025 S(2) 19,222 D $2.4004 1,314,804 I See footnote(3)
    Common Stock(1) 10/22/2025 S(2) 78,031 D $2.0727 1,236,773 I See footnote(3)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    Windsor Private Capital LP

    (Last) (First) (Middle)
    22 ST. CLAIR AVENUE EAST
    SUITE 202

    (Street)
    TORONTO A6 M4T 2S3

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    WPC Management Services Inc.

    (Last) (First) (Middle)
    22 ST. CLAIR AVENUE EAST
    SUITE 202

    (Street)
    TORONTO A6 M4T 2S3

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    WPC GP I Inc.

    (Last) (First) (Middle)
    22 ST. CLAIR AVENUE EAST
    SUITE 202

    (Street)
    TORONTO A6 M4T 2S3

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Kupinsky Jordan

    (Last) (First) (Middle)
    395 BROOKE AVENUE

    (Street)
    TORONTO A6 M5M 2L5

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    HJRK Holdings Inc.

    (Last) (First) (Middle)
    395 BROOKE AVENUE

    (Street)
    TORONTO A6 M5M 2L5

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    HJR Kupinsky 2013 Family Trust

    (Last) (First) (Middle)
    395 BROOKE AVENUE

    (Street)
    TORONTO A6 M5M 2L5

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Marcello Rocco

    (Last) (First) (Middle)
    22 ST. CLAIR AVENUE EAST
    SUITE 202

    (Street)
    TORONTO A6 M4T 2S3

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Cundari John

    (Last) (First) (Middle)
    22 ST. CLAIR AVENUE EAST
    SUITE 202

    (Street)
    TORONTO A6 M4T 2S3

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. This Form 4 is filed jointly by Windsor Private Capital LP ("Windsor"), WPC Management Services Inc. ("WPC Management Services"), WPC GP I Inc. ("WPC"), Jordan Kupinsky ("Mr. Kupinsky"), HJRK Holdings Inc. ("HJRK"), HJR Kupinsky 2013 Family Trust ("HJRK Trust"), Rocco Marcello ("Mr. Marcello") and John Cundari ("Mr. Cundari", and collectively, the "Reporting Persons"). The Reporting Persons are members of a "group" that beneficially owns more than 10% of the shares of common stock of Firefly Neurosciences, Inc. (the "Issuer").
    2. These transactions occurred pursuant to broker-dealer sales conducted in accordance with Rule 144 under the Securities Act of 1933, as amended. Following these transactions, the Reporting Persons are no longer beneficial owners of more than 10% of the Issuer's securities and as such, this filing represents an exit filing for the Reporting Persons.
    3. The reported securities are held directly by Windsor. Mr. Marcello is Founder, Chairman and Chief Executive Officer of Windsor. Mr. Cundari is President of Windsor. Mr. Kupinsky is Managing Partner of Windsor. WPC is the general partner of Windsor and WPC Management Services is the sole shareholder of WPC. Mr. Marcello, Mr. Cundari and Mr. Kupinsky are the directors of WPC and WPC Management Services. WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello and Mr. Cundari may be deemed to beneficially own the reported securities. WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello and Mr. Cundari disclaim beneficial ownership of the securities held directly by Windsor except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello or Mr. Cundari is a beneficial owner of such securities for purposes of Section 16 or any other purpose.
    Windsor Private Capital LP, by its General Partner, WPC GP I Inc., /s/ John Cundari, Partner 10/22/2025
    WPC Management Services Inc., /s/ John Cundari, Partner 10/22/2025
    WPC GP I Inc., /s/ John Cundari, Partner 10/22/2025
    /s/ Jordan Kupinsky 10/22/2025
    HJRK Holdings Inc., /s/ Jordan Kupinsky, President and Director 10/22/2025
    HJR Kupinsky 2013 Family Trust, by its Trustee, Jordan Kupinsky, /s/ Jordan Kupinsky 10/22/2025
    /s/ Rocco Marcello 10/22/2025
    /s/ John Cundari 10/22/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AIFF alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIFF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AIFF
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Firefly Neuroscience Inc.

    SCHEDULE 13D/A - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    10/23/25 6:39:23 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEFR14A filed by Firefly Neuroscience Inc.

    DEFR14A - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

    10/23/25 8:50:18 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by Firefly Neuroscience Inc.

    144 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    10/16/25 6:09:18 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Windsor Private Capital Lp sold $290,185 worth of shares (130,753 units at $2.22) (SEC Form 4)

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/22/25 6:36:23 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Large owner Windsor Private Capital Lp sold $269,154 worth of shares (102,675 units at $2.62) (SEC Form 4)

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/17/25 8:04:52 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Large owner Windsor Private Capital Lp sold $456,677 worth of shares (166,572 units at $2.74) (SEC Form 4)

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/14/25 7:15:01 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Financials

    Live finance-specific insights

    View All

    Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

    Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's dual go-to-market strategy TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its financial results for the third quarter ended September 30, 2024, and provided a stockholder update. Firefly is dedicated to improving outcomes for people suffering wi

    11/14/24 5:30:18 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Leadership Updates

    Live Leadership Updates

    View All

    Stran & Company Appoints Veteran Financial Executive Brian M. Posner to its Board of Directors

    Quincy, MA, July 10, 2025 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ:SWAG) (NASDAQ:SWAGW), a leading provider of outsourced marketing solutions specializing in promotional products and loyalty incentives, today announced the appointment of Brian M. Posner, MBA, to its Board of Directors. Mr. Posner will serve as Chairman of the Audit Committee. Brian Posner brings over four decades of public company financial leadership, strategic planning, and investor relations experience to the Company. Currently, Mr. Posner serves on the Board of Directors of Firefly Neuroscience, Inc. (NASDAQ:AIFF), where he also chairs the Audit Committee. Firefly is an artificial

    7/10/25 8:00:00 AM ET
    $AIFF
    $SWAG
    Computer Software: Prepackaged Software
    Technology
    Advertising
    Consumer Discretionary

    Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman

    TORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of current director of the Board, Greg Lipschitz, as Executive Chairman, effective as of December 3, 2024. "I look forward to taking on a more active leadership role as Executive Chairman," said Greg Lipschitz, newly appointed Executive Chairman of Firefly. "I believe that Firefly is uniquely positioned at the intersection of artificial intelligence and brain health that I have l

    12/4/24 9:00:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors

    TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of Stella Vnook, Ph.D. to its Board of Directors, effective as of August 19, 2024. Dr. Vnook will serve as Chairperson of the Nominating Committee. Dr. Vnook brings over 25 years of experience as a distinguished pharmaceutical executive, serial entrepreneur, CEO and founder of multiple biotech companies and visionary leader with a track record of success in biotechnology and life

    9/5/24 9:00:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    9/19/24 9:48:56 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    8/21/24 6:07:51 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    8/21/24 6:03:49 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

    KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced a new partnership with HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and transcranial magnetic stimulation ("TMS") clinics, and Advanced Behavioral Strategies (ABS). The collaboration comes on the heels of HealingMaps and Capstone Management Group announcing their official launch of the Healing Health Alliance*, the first-of-its-kind Group Purchasing Organization ("GPO"

    9/5/25 7:55:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen 'CLEAR' Platform

    – Unlocks exciting new AI-driven brain biomarker discovery and advancement capabilities – – Substantial processing speed gains while maintaining high signal quality standards – – Comes just months after Firefly announced its acceptance into the NVIDIA Connect Program – KENMORE, Wash. and NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to unveil its new ‘CLEAR' (CLeaning EEG ARtifacts) Platform, a proprietary next-generation preprocessing techno

    8/26/25 7:45:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

    – Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13.3 CNVs – – Collaboration aims to uncover novel insights into the brain's functional architecture in rare genetic conditions – – Building and growing a license business is an increasingly important pillar of Firefly's commercial strategy – KENMORE, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to highlight its ongoing collaboration with Prof. Dr. med. Chr

    7/14/25 7:45:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology